Clinical Trials Logo

Sensorineural Hearing Loss clinical trials

View clinical trials related to Sensorineural Hearing Loss.

Filter by:

NCT ID: NCT03938753 Completed - Hearing Loss Clinical Trials

Quality Control of CE-Certified Phonak Hearing Aids - 2018_42

Start date: January 9, 2019
Phase: N/A
Study type: Interventional

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

NCT ID: NCT03746613 Completed - Clinical trials for Sensorineural Hearing Loss

Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques

EAR2OS
Start date: September 24, 2018
Phase: N/A
Study type: Interventional

To assess the feasibility of achieving a minimally invasive access to the inner ear through the navigation-based HEARO procedure and subsequently insert the electrode array of the cochlear implant through the access.

NCT ID: NCT03718975 Completed - Hearing Loss Clinical Trials

Quality Control of CE-Certified Phonak Hearing Aids - 2018_28

Start date: September 10, 2018
Phase: N/A
Study type: Interventional

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical investigation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

NCT ID: NCT03616223 Completed - Clinical trials for Sensorineural Hearing Loss

FX-322 in Sensorineural Hearing Loss

Start date: July 3, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1/2 study of FX-322 at two dose levels compared to placebo in male and female adults otherwise healthy with stable sensorineural hearing loss.

NCT ID: NCT03467399 Completed - Clinical trials for Sensorineural Hearing Loss

Clinical Evaluation of a Cochlear Implant System

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

The primary objective of this study is to assess the usability of a Cochlear implant system.

NCT ID: NCT03288753 Completed - Clinical trials for Sensorineural Hearing Loss

Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors

Start date: October 2, 2017
Phase: N/A
Study type: Interventional

The present study aims to evaluate patient satisfaction and audiological performance with their current cochlear implant speech processor, the Neuro 1, and to compare it with the satisfaction and performance obtained with the new speech processor, the Neuro 2.

NCT ID: NCT03212924 Completed - Clinical trials for Sensorineural Hearing Loss

Listening Effort in Cochlear Implant Users

Start date: September 19, 2017
Phase: N/A
Study type: Interventional

Listening with a cochlear implant remains difficult and most listeners will report high levels of listening effort.The present study is a "pilot" aiming to evaluate listening effort for cochlear implant users. The listening effort is measured with pupillometry, by monitoring the variations of pupil size in response to different stimuli. The size of the pupil is known to increase with the listening effort. The listening effort is evaluated in two different situation: speech perception in quiet and speech perception in noise. The pupillometry measures will be compared for the two listening conditions. Moreover, the study will evaluate the relationship between objective (pupil dilatation) and subjective measures (auto evaluation) of listening effort, and between speech comprehension, cognitive abilities and listening effort.

NCT ID: NCT02798783 Completed - Clinical trials for Sensorineural Hearing Loss

Enlarged Vestibular Aqueduct Registry

EVAR
Start date: June 29, 2021
Phase:
Study type: Observational [Patient Registry]

People with the congenital anatomical malformation known as "Enlarged Vestibular Aqueduct" (EVA) may experience decline in hearing ability. This is an online registry to gather patient experiences with EVA, with the goal of providing future researchers with the information necessary to better evaluate and make recommendations for patients with EVA. Data will be obtained from volunteers who enroll and submit their information on a website, https://eva.uhhospitals.org, and a limited data set may be provided to researchers interested in analyzing repository data. The limited data set would not contain any identifiable information except for ages, dates such as date of diagnosis, or city/state of residence. EVA Research Project Website: http://rainbow.org/EVAResearch EVA Patient Registry Website: https://eva.uhhospitals.org

NCT ID: NCT02693704 Completed - Clinical trials for Sensorineural Hearing Loss

Evaluation of a Binaural Spatialization Method for Hearing Aids

BHA(L&S)
Start date: February 2016
Phase: Phase 2/Phase 3
Study type: Interventional

This study investigates the possible benefits of using binaural spatialization techniques in digital wireless microphone systems for hearing aids. Speech intelligibility tests, speaker localization tests and preference tests are performed. The results of a diotic (current rendering) and a binaural (suggested rendering) rendering are compared.

NCT ID: NCT02689349 Completed - Clinical trials for Sensorineural Hearing Loss

Esteem New Subject Enrollment Post Approval Study

Start date: August 2010
Phase: N/A
Study type: Interventional

The New Enrollment Post-Approval Study is designed to evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from moderate to severe hearing loss.